At the 2nd Congress of the European Academy of Neurology (EAN), held in Copenhagen, Denmark, from May 28–31 2016, Jakub Hort, MD, PhD, from University in Prague, Czech Republic, provides an overview of the current clinical development of novel pharmacological treatments for people with Alzheimer’s disease, with a focus on approaches that address neuropsychiatric symptoms and disease-modifying therapies.
